FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 218808 | NDA | NEUROCRINE | | 001 | CRENESSITY | CAPSULE;ORAL | 25MG | CRINECERFONT | 2024-12-13 | Prescription | No |
| 002 | CRENESSITY | CAPSULE;ORAL | 50MG | CRINECERFONT | 2024-12-13 | Prescription | No |
| 003 | CRENESSITY | CAPSULE;ORAL | 100MG | CRINECERFONT | 2024-12-13 | Prescription | Yes |
| 218820 | NDA | NEUROCRINE | | 001 | CRENESSITY | SOLUTION;ORAL | 50MG/ML | CRINECERFONT | 2024-12-13 | Prescription | Yes |
| 218390 | NDA | NEUROCRINE | | 001 | INGREZZA SPRINKLE | CAPSULE;ORAL | EQ 40MG BASE | VALBENAZINE TOSYLATE | 2024-04-30 | Prescription | No |
| 002 | INGREZZA SPRINKLE | CAPSULE;ORAL | EQ 60MG BASE | VALBENAZINE TOSYLATE | 2024-04-30 | Prescription | No |
| 003 | INGREZZA SPRINKLE | CAPSULE;ORAL | EQ 80MG BASE | VALBENAZINE TOSYLATE | 2024-04-30 | Prescription | Yes |
| 209241 | NDA | NEUROCRINE | | 001 | INGREZZA | CAPSULE;ORAL | EQ 40MG BASE | VALBENAZINE TOSYLATE | 2017-04-11 | Prescription | No |
| 002 | INGREZZA | CAPSULE;ORAL | EQ 80MG BASE | VALBENAZINE TOSYLATE | 2017-04-11 | Prescription | Yes |
| 003 | INGREZZA | CAPSULE;ORAL | EQ 60MG BASE | VALBENAZINE TOSYLATE | 2017-04-11 | Prescription | No |